Journal List > Perinatology > v.30(4) > 1144128

Lee, Park, and Bae: Perinatal Outcomes Following Prolonged Preterm Premature Rupture of Membranes before Limit of Viability – A Single Center Experience

Abstract

Objective

To investigate maternal and neonatal outcomes following prolonged preterm premature rupture of membrane (PPROM) before limit of viability in a single center.

Methods

Thirty-two women with PPROM before 25 weeks' gestation without overt intrauterine infection were administered expectant management. We investigated maternal and neonatal outcomes of pregnancies following PPROM occurring before 25 weeks' gestation and with latent period (from membrane rupture to delivery) of 7 days or more.

Results

Median gestational age at membrane rupture was 22.1 weeks. Median latent period was 32 days. Median gestational age at delivery was 26.6 weeks. The incidence of clinical pulmonary hypo plasia and early onset sepsis was 43.5% (10/23) and 21.7% (5/23), respectively. The overall mortality in neonatal intensive care unit (NICU) was 43.5% (10/23). Latent period was negatively correlated with gestational age at membrane rupture (r=-0.501, P=0.015), but not associated with maternal complications. As the length of latent period increased, overall mortality in NICU decreased (relative risk=0.898, P=0.011).

Conclusion

The expectant management in women with PPROM before 25 weeks' gestation did not induce maternal complications and might help to improve the neonatal outcomes rather than the immediate delivery.

References

1. Mercer BM. Preterm premature rupture of the membranes. Obstet Gynecol. 2003; 101:178–93.
crossref
2. Melamed N, Hadar E, Ben-Haroush A, Kaplan B, Yogev Y. Factors affecting the duration of the latency period in preterm premature rupture of membranes. J Matern Fetal Neonatal Med. 2009; 22:1051–6.
crossref
3. Kenyon S, Boulvain M, Neilson JP. Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev. 2010; 8:CD001058.
crossref
4. Garite TJ, Freeman RK. Chorioamnionitis in the preterm gestation. Obstet Gynecol. 1982; 59:539–45.
5. Beydoun SN, Yasin SY. Premature rupture of the membranes before 28 weeks: conservative management. Am J Obstet Gynecol. 1986; 155:4719.
crossref
6. American College of Obstetrics and Gynecology. ACOG practice bulletin. Perinatal care at the threshold of viability. Number 38, September 2002. American College of Obstetrics and Gynecology. Int J Gynaecol Obstet. 2002; 79:181–8.
7. Yeast JD. Preterm premature rupture of the membranes before viability. Clin Perinatol. 2001; 28:849–60.
crossref
8. Taylor J, Garite TJ. Premature rupture of membranes before fetal viability. Obstet Gynecol. 1984; 64:615–20.
9. Major CA, Kitzmiller JL. Perinatal survival with expectant management of midtrimester rupture of membranes. Am J Obstet Gynecol. 1990; 163:838–44.
crossref
10. Xiao ZH, André P, Lacaze-Masmonteil T, Audibert F, Zupan V, Dehan M. Outcome of premature infants delivered after prolonged premature rupture of membranes before 25 weeks of gestation. Eur J Obstet Gynecol Reprod Biol. 2000; 90:67–71.
crossref
11. Muris C, Girard B, Creveuil C, Durin L, Herlicoviez M, Dreyfus M. Management of premature rupture of membranes before 25 weeks. Eur J Obstet Gynecol Reprod Biol. 2007; 131:163–8.
crossref
12. Manuck TA, Eller AG, Esplin MS, Stoddard GJ, Varner MW, Silver RM. Outcomes of expectantly managed preterm premature rupture of membranes occurring before 24 weeks of gestation. Obstet Gynecol. 2009; 114:29–37.
crossref
13. Williams O, Hutchings G, Debieve F, Debauche C. Contemporary neonatal outcome following rupture of membranes prior to 25 weeks with prolonged oligohydramnios. Early Hum Dev. 2009; 85:273–7.
14. Brumbaugh JE, Colaizy TT, Nuangchamnong N, O'Brien EA, Fleener DK, Rijhsinghani A, et al. Neonatal survival after prolonged preterm premature rupture of membranes before 24 weeks of gestation. Obstet Gynecol. 2014; 124:992–8.
crossref
15. Kibel M, Asztalos E, Barrett J, Dunn MS, Tward C, Pittini A, et al. Outcomes of pregnancies complicated by preterm premature rupture of membranes between 20 and 24 weeks of gestation. Obstet Gynecol. 2016; 128:313–20.
crossref
16. Kilbride HW, Thibeault DW. Neonatal complications of preterm premature rupture of membranes. Pathophysiology and management. Clin Perinatol. 2001; 28:761–85.
crossref
17. Kilbride HW, Yeast J, Thibeault DW. Defining limits of survival: lethal pulmonary hypoplasia after midtrimester premature rupture of membranes. Am J Obstet Gynecol. 1996; 175:675–81.
crossref
18. Everest NJ, Jacobs SE, Davis PG, Begg L, Rogerson S. Outcomes following prolonged preterm premature rupture of the membranes. Arch Dis Child Fetal Neonatal Ed. 2008; 93:F207–11.
crossref
19. Rotschild A, Ling EW, Puterman ML, Farquharson D. Neonatal outcome after prolonged preterm rupture of the membranes. Am J Obstet Gynecol. 1990; 162:46–52.
crossref
20. Winn HN, Chen M, Amon E, Leet TL, Shumway JB, Mostello D. Neonatal pulmonary hypoplasia and perinatal mortality in patients with midtrimester rupture of amniotic membranes–a critical analysis. Am J Obstet Gynecol. 2000; 182:1638–44.
crossref
21. Waters TP, Mercer BM. The management of preterm premature rupture of the membranes near the limit of fetal viability. Am J Obstet Gynecol. 2009; 201:230–40.
crossref
22. Lee J, Romero R, Kim SM, Chaemsaithong P, Park CW, Park JS, et al. A new antimicrobial combination prolongs the latency period, reduces acute histologic chorioamnionitis as well as funisitis, and improves neonatal outcomes in preterm PROM. J Matern Fetal Neonatal Med. 2016; 29:707–20.
crossref
23. Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin No. 188: prelabor rupture of membranes. Obstet Gynecol. 2018; 131:e1–14.
24. Gibbs RS, Romero R, Hillier SL, Eschenbach DA, Sweet RL. A review of premature birth and subclinical infection. Am J Obstet Gynecol. 1992; 166:1515–28.
crossref
25. Redline RW, Faye-Petersen O, Heller D, Qureshi F, Savell V, Vogler C. Amniotic infection syndrome: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol. 2003; 6:435–48.
crossref
26. Zaichkin JG. Neonatal resuscitation: neonatal resuscitation program 7th edition practice integration. Crit Care Nurs Clin North Am. 2018; 30:53347.
27. Suzuki K. Respiratory characteristics of infants with pulmonary hypoplasia syndrome following preterm rupture of membranes: a preliminary study for establishing clinical diagnostic criteria. Early Hum Dev. 2004; 79:31–40.
crossref
28. Hadi HA, Hodson CA, Strickland D. Premature rupture of the membranes between 20 and 25 weeks' gestation: role of amniotic fluid volume in perinatal outcome. Am J Obstet Gynecol. 1994; 170:1139–44.
crossref
29. Joshi S, Kotecha S. Lung growth and development. Early Hum Dev. 2007; 83:789–94.
crossref
30. McMurtry IF. Introduction: pre-and postnatal lung development, maturation, and plasticity. Am J Physiol Lung Cell Mol Physiol. 2002; 282:L341–4.
31. Singh K, Mercer B. Antibiotics after preterm premature rupture of the membranes. Clin Obstet Gynecol. 2011; 54:344–50.
crossref
32. Bromiker R, Ernest N, Meir MB, Kaplan M, Hammerman C, Schimmel MS, et al. Correlation of bacterial type and antibiotic sensitivity with maternal antibiotic exposure in early-onset neonatal sepsis. Neonatology. 2013; 103:48–53.
crossref

Fig. 1.
Flowchart of pregnant women and infants with PPROM before 25 weeks of gestation. PPROM, prolonged preterm premature rupture of membrane; GA, gestaional age; NICU, neonatal intensive care unit.
pn-30-193f1.tif
Table 1.
Maternal Characteristics and Outcomes
Variable Women (n=21)
Maternal age (years) 34 (32–36)
Nulliparity 8 (38.1)
Para 1 (0–2)
Multiple pregnancy 5 (23.8)
Cerclage intervention 7 (33.3)
Amniocentesis before membrane rupture 0
GA at membrane rupture (weeks) 22.1 (21.0–23.1)
Latent period (days) 32 (23–58)
3) 3/mm WBC at admission (10 12.6 (8.7–15.1)
CRP at admission (mg/L) 0.6 (0.1–1.8)
GA at delivery (weeks) 26.6 (25.7–29.9)
Cesarean section 16 (76.2)
Clinical chorioamnionitis 11 (52.4)
Histologic chorioamnionitis 12 (75.0)
Maternal sepsis 3 (14.3)
Retained placenta necessitating curettage 2 (9.5)
Placenta abruptio 0

Values are presented as median (interquartile range) or number (%). Abbreviations: GA, gestational age; WBC, white blood cell; CRP, C-reactive protein.

Table 2.
Neontal Characteristics and Outcomes
Variable Neonate (n=23)
GA at delivery (weeks) 27.7 (25.7–29.7)
Birth weight (g) 1,050 (780–1,420)
MVP at membrane rupture (mm) 31 (17–53)
5-minutes Apgar score 8 (7–8)
Clinical pulmonary hypoplasia 10 (43.5)
Air leak syndrome 6 (26.1)
Persistent fetal circulation 7 (30.4)
Perinatal death at postnatal 7 days 4 (17.4)
Early onset sepsis 5 (21.7)
Moderate to severe BPD 4 (17.4)
Overall mortality in NICU 10 (43.5)

Values are presented as median (interquartile range) or number (%). Abbreviations: GA, gestational age; MVP, maximum vertical pocket; BPD, bronchopulmonary dysplasia; NICU, neonatal intensive care unit.

Table 3.
Infants Who Died in Neonatal Intensive Care Unit
No. GA at membrane rupture (weeks) MVP at membrane rupture (mm) Latent period (days) GA at delivery (weeks) Birth I weight (g) Intubated at birth Clinical pulmonary hypoplasia Air leak syndrome Persistent fetal circulation Early onset sepsis Postnata age at death (days) al Cause of death
1 19.7 60 32 24.3 620 + 7 Respiratory failure
2 21.1 0 25 24.7 650 + + + 0 Respiratory failure
3 21.1 53 25 24.7 710 + + 9 Infection
4 22.4 41 13 24.3 780 + 56 Necrotizing enterocolitis
5 22.6 0 22 25.7 770 + + + + 7 Respiratory failure
6 22.7 0 27 26.6 1,050 + 12 Respiratory failure
7 22.7 64 12 24.4 660 + 10 Intraventricular hemorrhage
8 23.0 40 39 28.6 1,320 + + 1 Respiratory failure
9 23.7 17 15 25.9 970 + 35 Infection
10 24.4 27 23 27.7 1,070 + + + + 2 Respiratory failure

Abbreviations: GA, gestational age; MVP, maximum vertical pocket.

Table 4.
Infants Who Survived in Neonatal Intensive Care Unit
No. GA at membrane rupture (weeks) MVP at membrane rupture (mm) Latent period (days) GA at delivery (weeks) Birth weight (g) Intubated at birth Clinical pulmonary hypoplasia Air leak syndrome Persistent fetal circulation Early onset sepsis BPD, moderate to severe Hospitalization (days)
1 19.7 18 83 31.6 1,640 + + + + + + 147
2 19.9 60 72 30.4 1,560 43
3 20.9 26 54 28.6 1,070 + + + 63
4 20.9 45 54 28.6 1,100 + + + 74
5 21.0 40 36 30.0 1,720 + 43
6 21.1 24 53 28.7 1,320 + + + + 63
7 21.7 26 56 29.7 1,420 + + + + + 54
8 21.7 47 56 29.7 1,580 + 46
9 22.0 56 60 30.6 920 + + + 157
10 22.1 0 25 25.7 930 + + 84
11 23.1 31 18 25.7 900 + + 115
12 23.7 0 20 26.6 790 + + 108
13 23.9 69 74 34.4 2,580 6

Abbreviations: GA, gestational age; MVP, maximum vertical pocket; BPD, bronchopulmonary dysplasia.

Table 5.
Correlation Coefficient between Perinatal Parameters and Latent Period
Perinatal parameters Latent period
Perinatal parameters r P-value
GA at membrane rupture (weeks) –0.501 0.015
MVP at membrane rupture (mm) 0.327 0.128
GA at delivery (weeks) 0.903 <0.001
Birth weight (g) 0.785 <0.001
5-minutes Apgar score 0.135 0.540

Abbreviations: GA, gestaitonal age; MVP, maximum vertical pocket.

Table 6.
Maternal and Neonatal Outcomes Associated with Latent Period from Membrane Rupture to Delivery
Outcomes Relative risk (95% CI) P-value
Maternal 0.968 (0.926–1.012) 0.147
Clinical chorioamnionitis 0.968 (0.926–1.012) 0.147
Histologic chorioamnionitis 1.005 (0.965–1.047) 0.795
Maternal sepsis 0.952 (0.870–1.041) 0.281
Retained placenta necessitating curettage 1.056 (0.975–1.145) 0.182
Neonatal    
Clinical pulmonary hypoplasia 1.028 (0.987–1.071) 0.189
Air leak syndrome 1.028 (0.983–1.076) 0.223
Persistent fetal circulation 1.031 (0.987–1.077) 0.167
Perinatal death at postnatal 7 days 0.958 (0.896–1.026) 0.221
Early onset sepsis 1.023 (0.977–1.072) 0.335
Overall mortality in NICU 0.898 (0.827–0.976) 0.011

Abbreviations: CI, confidence interval; NICU, neonatal intensive care unit.

TOOLS
Similar articles